What is Biohaven's net income?

Biohaven (BHVN) reported net income of -$130.53M in Q1 2026.

How has Biohaven's net income changed year-over-year?

Biohaven's net income increased by 41.1% year-over-year, from -$221.68M to -$130.53M.

What is the long-term trend for Biohaven's net income?

Over 4 years (2021 to 2025), Biohaven's net income has grown at a 36.3% compound annual growth rate (CAGR), from -$213.8M to -$738.82M.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Biohaven (BHVN) Net Income — Quarterly & Annual

Screener

Net Income at other companies

Eli LillyLLY

$7.1B+25.3%

Xenon PharmaceuticalsXENE

-$110.74M-30.7%

Rapport Therapeutics, Inc.RAPP

-$56.62M-112%

Vir Biotechnology, Inc.VIR

$80.08M+172%

Monte Rosa Therapeutics, Inc.GLUE

-$43.4M-253%

Avalo TherapeuticsAVTX

-$36.36M-75.1%

Segments

By segment

See full

Reportable Segment-$130.53M+41.1%

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.17B+41.2%

Enterprise value$2.18B+31.3%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Biohaven’s 10-Q, filed May 4, 2026.

Filed: May 4, 2026, 4:07 PM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001935979-26-000045

Line item	Three Months Ended March 31, 2026	Three Months Ended March 31, 2025
Other income, net	168	493
Loss before provision for income taxes	(130,260)	(221,068)
Provision for income taxes	272	609
Net loss	$(130,532)	$(221,677)
Net loss per share — basic and diluted	$(0.88)	$(2.17)
Weighted average common shares outstanding—basic and diluted	147,615,197	101,943,396
Comprehensive loss:
Net loss	$(130,532)	$(221,677)

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Biohaven's net income?: Biohaven (BHVN) reported net income of -$130.53M in Q1 2026.
How has Biohaven's net income changed year-over-year?: Biohaven's net income increased by 41.1% year-over-year, from -$221.68M to -$130.53M.
What is the long-term trend for Biohaven's net income?: Over 4 years (2021 to 2025), Biohaven's net income has grown at a 36.3% compound annual growth rate (CAGR), from -$213.8M to -$738.82M.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.